Citigroup Inc Co Diagnostics, Inc. Transaction History
Citigroup Inc
- $217 Billion
- Q3 2025
A detailed history of Citigroup Inc transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 1,456 shares of CODX stock, worth $495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,456
Previous 5,381
72.94%
Holding current value
$495
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CODX
# of Institutions
39Shares Held
5.57MCall Options Held
58KPut Options Held
31.8K-
Vanguard Group Inc Valley Forge, PA1.71MShares$580,0230.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$401,7550.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny868KShares$294,9570.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$170,6880.0% of portfolio
-
Geode Capital Management, LLC Boston, MA320KShares$108,7960.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $11.5M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...